{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:35:24Z","timestamp":1789425324785,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Broflanilide is a newly discovered insecticide with a novel mode of action targeting insect \u03b3-aminobutyric acid receptors. The efficacy of VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500, a wettable powder formulation of broflanilide, was assessed for IRS against wild pyrethroid-resistant malaria vectors in experimental huts in Benin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 was evaluated at 100\u00a0mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      in mud and cement-walled experimental huts against wild pyrethroid-resistant\n                      <jats:italic>Anopheles gambiae<\/jats:italic>\n                      sensu lato (\n                      <jats:italic>s.l.<\/jats:italic>\n                      ) in Cov\u00e8, southern Benin, over 18\u00a0months. A direct comparison was made with Actellic\u00ae 300CS, a WHO-recommended micro-encapsulated formulation of pirimiphos-methyl, applied at 1000\u00a0mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . The vector population at Cov\u00e8 was investigated for susceptibility to broflanilide and other classes of insecticides used for vector control. Monthly wall cone bioassays were performed to assess the residual efficacy of VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 using insecticide susceptible\n                      <jats:italic>An. gambiae<\/jats:italic>\n                      Kisumu and pyrethroid-resistant\n                      <jats:italic>An. gambiae s.l.<\/jats:italic>\n                      Cov\u00e8 strains. The study complied with OECD principles of good laboratory practice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The vector population at Cov\u00e8 was resistant to pyrethroids and organochlorines but susceptible to broflanilide and pirimiphos-methyl. A total of 23,171 free-flying wild pyrethroid-resistant female\n                      <jats:italic>An. gambiae s.l.<\/jats:italic>\n                      were collected in the experimental huts over 12\u00a0months. VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 induced 56%-60% mortality in wild vector mosquitoes in both cement and mud-walled huts. Mortality with VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 was 62%-73% in the first three months and remained\u2009&gt;\u200950% for 9\u00a0months on both substrate-types. By comparison, mortality with Actellic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      300CS was very high in the first three months (72%-95%) but declined sharply to\u2009&lt;\u200940% after 4\u00a0months. Using a non-inferiority margin defined by the World Health Organization, overall mortality achieved with VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 was non-inferior to that observed in huts treated with Actellic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      300CS with both cement and mud wall substrates. Monthly in situ wall cone bioassay mortality with VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 also remained over 80% for 18\u00a0months but dropped below 80% with Actellic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      300CS at 6\u20137\u00a0months post spraying.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      VECTRON\n                      <jats:sup>\u2122<\/jats:sup>\n                      T500 shows potential to provide substantial and prolonged control of malaria transmitted by pyrethroid-resistant mosquito vectors when applied for IRS. Its addition to the current list of WHO-approved IRS insecticides will provide a suitable option to facilitate rotation of IRS products with different modes of action.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-022-04336-x","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T09:03:03Z","timestamp":1668157383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["VECTRON\u2122 T500, a new broflanilide insecticide for indoor residual spraying, provides prolonged control of pyrethroid-resistant malaria vectors"],"prefix":"10.1186","volume":"21","author":[{"given":"Renaud","family":"Govoetchan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Fongnikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Syme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martial","family":"Gbegbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Todjinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derric","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germain Gil","family":"Padonou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine","family":"Ngufor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"4336_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207\u201311.","journal-title":"Nature"},{"key":"4336_CR2","unstructured":"WHO. Guidelines for malaria vector control. Geneva, World Health Organization, 2019."},{"key":"4336_CR3","unstructured":"WHO. Indoor residual spraying : use of indoor residual spraying for scaling up global malaria control and elimination. WHO position statement. Geneva, World Health Organization 2006 https:\/\/apps.who.int\/iris\/handle\/10665\/69386."},{"key":"4336_CR4","first-page":"45","volume":"19","author":"MC Akogbeto","year":"2020","unstructured":"Akogbeto MC, Dagnon F, Aikpon R, Osse R, Salako AS, Ahogni I, et al. Lessons learned, challenges and outlooks for decision-making after a decade of experience monitoring the impact of indoor residual spraying in Benin. West Africa Malar J. 2020;19:45.","journal-title":"West Africa Malar J"},{"key":"4336_CR5","first-page":"52","volume":"6","author":"BL Sharp","year":"2007","unstructured":"Sharp BL, Ridl FC, Govender D, Kuklinski J, Kleinschmidt I. Malaria vector control by indoor residual insecticide spraying on the tropical island of Bioko. Equatorial Guinea Malar J. 2007;6:52.","journal-title":"Equatorial Guinea Malar J"},{"key":"4336_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12936-021-03583-8","volume":"20","author":"JM Wagman","year":"2021","unstructured":"Wagman JM, Varela K, Zulliger R, Saifodine A, Muthoni R, Magesa S, et al. Reduced exposure to malaria vectors following indoor residual spraying of pirimiphos-methyl in a high-burden district of rural Mozambique with high ownership of long-lasting insecticidal nets: entomological surveillance results from a cluster-randomized trial. Malar J. 2021;20:54.","journal-title":"Malar J"},{"key":"4336_CR7","first-page":"CD006657","volume":"2010","author":"B Pluess","year":"2010","unstructured":"Pluess B, Tanser FC, Lengeler C, Sharp BL. Indoor residual spraying for preventing malaria. Cochrane Database Syst Rev. 2010;2010:CD006657.","journal-title":"Cochrane Database Syst Rev"},{"key":"4336_CR8","unstructured":"WHO. Global report on insecticide resistance in malaria vectors: 2010\u20132016. Geneva, World Health Organization, 2018."},{"key":"4336_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12936-016-1201-1","volume":"15","author":"RM Oxborough","year":"2016","unstructured":"Oxborough RM. Trends in US President\u2019s Malaria Initiative-funded indoor residual spray coverage and insecticide choice in sub-Saharan Africa (2008\u20132015): urgent need for affordable, long-lasting insecticides. Malar J. 2016;15:146.","journal-title":"Malar J"},{"key":"4336_CR10","unstructured":"WHO. World Malaria Report 2021. Geneva, World Health Organization, 2021, https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2021."},{"key":"4336_CR11","first-page":"3","volume":"19","author":"RY A\u00efkpon","year":"2020","unstructured":"A\u00efkpon RY, Padonou G, Dagnon F, Oss\u00e8 R, Ogouyemi Hounto A, Tokponon F, et al. Upsurge of malaria transmission after indoor residual spraying withdrawal in Atacora region in Benin. West Africa Malar J. 2020;19:3.","journal-title":"West Africa Malar J"},{"key":"4336_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/cid\/cix251","volume":"65","author":"S Raouf","year":"2017","unstructured":"Raouf S, Mpimbaza A, Kigozi R, Sserwanga A, Rubahika D, Katamba H, et al. Resurgence of malaria following discontinuation of indoor residual spraying of insecticide in an area of Uganda with previously high-transmission intensity. Clin Infect Dis. 2017;65:453\u201360.","journal-title":"Clin Infect Dis"},{"key":"4336_CR13","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1038\/s41467-021-22896-5","volume":"12","author":"JF Namuganga","year":"2021","unstructured":"Namuganga JF, Epstein A, Nankabirwa JI, Mpimbaza A, Kiggundu M, Sserwanga A, et al. The impact of stopping and starting indoor residual spraying on malaria burden in Uganda. Nat Commun. 2021;12:2635.","journal-title":"Nat Commun"},{"key":"4336_CR14","unstructured":"WHO. Global Plan for Insecticide Resistance Management in Malaria Vectors. Geneva, World Health Organization 2012."},{"key":"4336_CR15","unstructured":"WHO Prequalification of Medical Products (IVDs M, Vaccines and Immunization Devices, Vector Control). Geneva, World Health Organization, 2022.  https:\/\/extranetwhoint\/pqweb\/vector-control-products\/prequalified-product-list"},{"key":"4336_CR16","unstructured":"IRAC. The IRAC Mode of Action Classification Online. https:\/\/irac-online.org\/modesofaction\/ Accessed 27 Jan 2022."},{"key":"4336_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.bmc.2015.08.008","volume":"24","author":"T Nakao","year":"2016","unstructured":"Nakao T, Banba S. Broflanilide: a meta-diamide insecticide with a novel mode of action. Bioorg Med Chem. 2016;24:372\u20137.","journal-title":"Bioorg Med Chem"},{"key":"4336_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pestbp.2020.104587","volume":"167","author":"TC Sparks","year":"2020","unstructured":"Sparks TC, Crossthwaite AJ, Nauen R, Banba S, Cordova D, Earley F, et al. Insecticides, biologics and nematicides: updates to IRAC\u2019s mode of action classification - a tool for resistance management. Pestic Biochem Physiol. 2020;167: 104587.","journal-title":"Pestic Biochem Physiol"},{"key":"4336_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ibmb.2013.02.002","volume":"43","author":"T Nakao","year":"2013","unstructured":"Nakao T, Banba S, Nomura M, Hirase K. Meta-diamide insecticides acting on distinct sites of RDL GABA receptor from those for conventional noncompetitive antagonists. Insect Biochem Mol Biol. 2013;43:366\u201375.","journal-title":"Insect Biochem Mol Biol"},{"key":"4336_CR20","first-page":"112","volume":"43","author":"H Qi","year":"2017","unstructured":"Qi H, Cui L, Wang Q, Liu F, Rui C. Toxicity of broflanilide to Plutella xylostella and its influence on the activities of related enzymes in P. xylostella. Plant Prot. 2017;43:112\u20136.","journal-title":"Plant Prot"},{"key":"4336_CR21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ps.6719","volume":"78","author":"N Shen","year":"2022","unstructured":"Shen N, Liu HY, Mou TY, Ma YB, Li Y, Song ZJ, et al. Novel meta-diamide insecticide, broflanilide, suppresses the population of common cutworm Spodoptera litura through its lethal and sublethal effects. Pest Manag Sci. 2022;78:1081\u20139.","journal-title":"Pest Manag Sci"},{"key":"4336_CR22","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1002\/ps.6335","volume":"77","author":"N Shen","year":"2021","unstructured":"Shen N, Li Y, Leviticus K, Chang XL, Tang T, Cui L, et al. Effect of broflanilide on the phytophagous mite Tetranychus urticae and the predatory mite Typhlodromips swirskii. Pest Manag Sci. 2021;77:2964\u201370.","journal-title":"Pest Manag Sci"},{"key":"4336_CR23","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1038\/s41598-021-86935-3","volume":"11","author":"C Ngufor","year":"2021","unstructured":"Ngufor C, Govoetchan R, Fongnikin A, Vigninou E, Syme T, Akogbeto M, et al. Efficacy of broflanilide (VECTRON T500), a new meta-diamide insecticide, for indoor residual spraying against pyrethroid-resistant malaria vectors. Sci Rep. 2021;11:7976.","journal-title":"Sci Rep"},{"key":"4336_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12936-020-03466-4","volume":"19","author":"RS Lees","year":"2020","unstructured":"Lees RS, Ambrose P, Williams J, Morgan J, Praulins G, Ingham VA, et al. Tenebenal: a meta-diamide with potential for use as a novel mode of action insecticide for public health. Malar J. 2020;19:398.","journal-title":"Malar J"},{"key":"4336_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248026","volume":"16","author":"J Snetselaar","year":"2021","unstructured":"Snetselaar J, Rowland MW, Manunda BJ, Kisengwa EM, Small GJ, Malone DJ, et al. Efficacy of indoor residual spraying with broflanilide (TENEBENAL), a novel meta-diamide insecticide, against pyrethroid-resistant anopheline vectors in northern Tanzania: an experimental hut trial. PLoS ONE. 2021;16: e0248026.","journal-title":"PLoS ONE"},{"key":"4336_CR26","unstructured":"WHO. The evaluation process for vector control products. Geneva, World Health Organization, 2017."},{"key":"4336_CR27","unstructured":"WHO. Data requirements and protocol for determining non-inferiority of insecticide-treated net and indoor residual spraying products within an established WHO intervention class. Geneva, World Health Organization, 2018. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/276039\/WHO-CDS-GMP-2018.22-eng.pdf?ua=1."},{"key":"4336_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12936-015-0981-z","volume":"14","author":"C Ngufor","year":"2015","unstructured":"Ngufor C, N\u2019Guessan R, Fagbohoun J, Subramaniam K, Odjo A, Fongnikin A, et al. Insecticide resistance profile of Anopheles gambiae from a phase II field station in Cove, southern Benin: implications for the evaluation of novel vector control products. Malar J. 2015;14:464.","journal-title":"Malar J"},{"key":"4336_CR29","unstructured":"WHO. Guidelines for testing mosquito adulticides for indoor residual spraying and treatment of mosquito nets. Geneva, World Health Organization, 2006."},{"key":"4336_CR30","unstructured":"WHO. Test procedures for insecticide resistance monitoring in malaria vector mosquitoes. Geneva, World Health Organization, 2016."},{"key":"4336_CR31","unstructured":"WHO. Data requirements and protocol for determining non-inferiority of insecticide-treated net and indoor residual spraying products within an established WHO policy class (No. WHO\/CDS\/GMP\/2018.22. Rev. 1). Geneva, World Health Organization, 2019."},{"key":"4336_CR32","unstructured":"WHO. Global Technical Strategy for malaria 2016\u20132030. Geneva, World Health Organization, 2015."},{"key":"4336_CR33","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1038\/s41598-020-61350-2","volume":"10","author":"B Abong'o","year":"2020","unstructured":"Abong\u2019o B, Gimnig JE, Torr SJ, Longman B, Omoke D, Muchoki M, et al. Impact of indoor residual spraying with pirimiphos-methyl (Actellic 300CS) on entomological indicators of transmission and malaria case burden in Migori County, western Kenya. Sci Rep. 2020;10:4518.","journal-title":"Sci Rep"},{"key":"4336_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/trstmh\/trt117","volume":"108","author":"FR Agossa","year":"2014","unstructured":"Agossa FR, Aikpon R, Azondekon R, Govoetchan R, Padonnou GG, Oussou O, et al. Efficacy of various insecticides recommended for indoor residual spraying. pirimiphos methyl, potential alternative to bendiocarb for pyrethroid resistance management in Benin, West Africa. Trans R Soc Trop Med Hyg. 2014;108:84\u201391.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4336_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151971","volume":"11","author":"M Kanyangarara","year":"2016","unstructured":"Kanyangarara M, Mamini E, Mharakurwa S, Munyati S, Gwanzura L, Kobayashi T, et al. Reduction in malaria incidence following indoor residual spraying with Actellic 300 CS in a setting with pyrethroid resistance: Mutasa District. Zimbabwe PLoS One. 2016;11: e0151971.","journal-title":"Zimbabwe PLoS One"},{"key":"4336_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1475-2875-13-37","volume":"13","author":"RM Oxborough","year":"2014","unstructured":"Oxborough RM, Kitau J, Jones R, Feston E, Matowo J, Mosha FW, et al. Long-lasting control of Anopheles arabiensis by a single spray application of micro-encapsulated pirimiphos-methyl (Actellic(R) 300 CS). Malar J. 2014;13:37.","journal-title":"Malar J"},{"key":"4336_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s13071-019-3865-1","volume":"12","author":"AS Salako","year":"2019","unstructured":"Salako AS, Dagnon F, Sovi A, Padonou GG, Aikpon R, Ahogni I, S, et al. Efficacy of Actellic 300 CS-based indoor residual spraying on key entomological indicators of malaria transmission in Alibori and Donga, two regions of northern Benin. Parasit Vectors. 2019;12:612.","journal-title":"Parasit Vectors"},{"key":"4336_CR38","unstructured":"WHO. Preferred product characteristics: indoor residual spraying products for malaria transmission control in areas with insecticide-resistant mosquito populations; Draft for public consultation. Geneva, World Health Organization, 2021. https:\/\/cdn.who.int\/media\/docs\/default-source\/malaria\/ppcs-etc\/who-ucn-gmp-2021-02-eng.pdf?sfvrsn=dbd89f86_10."},{"key":"4336_CR39","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s13071-020-04341-6","volume":"13","author":"A Fongnikin","year":"2020","unstructured":"Fongnikin A, Houeto N, Agbevo A, Odjo A, Syme T, N\u2019Guessan R, et al. Efficacy of Fludora\u00ae Fusion (a mixture of deltamethrin and clothianidin) for indoor residual spraying against pyrethroid-resistant malaria vectors: laboratory and experimental hut evaluation. Parasit Vectors. 2020;13:466.","journal-title":"Parasit Vectors"},{"key":"4336_CR40","first-page":"484","volume":"17","author":"FR Agossa","year":"2018","unstructured":"Agossa FR, Padonou GG, Fassinou A, Odjo EM, Akuoko OK, Salako A, et al. Small-scale field evaluation of the efficacy and residual effect of Fludora((R)) Fusion (mixture of clothianidin and deltamethrin) against susceptible and resistant Anopheles gambiae populations from Benin. West Africa Malar J. 2018;17:484.","journal-title":"West Africa Malar J"},{"key":"4336_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13071-018-2869-6","volume":"11","author":"FR Agossa","year":"2018","unstructured":"Agossa FR, Padonou GG, Koukpo CZ, Zola-Sahossi J, Azondekon R, Akuoko OK, et al. Efficacy of a novel mode of action of an indoor residual spraying product, SumiShield(R) 50WG against susceptible and resistant populations of Anopheles gambiae (s.l.) in Benin. West Africa Parasit Vectors. 2018;11:293.","journal-title":"West Africa Parasit Vectors"},{"key":"4336_CR42","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3201\/eid1807.120218","volume":"18","author":"A Asidi","year":"2012","unstructured":"Asidi A, N\u2019Guessan R, Akogbeto M, Curtis C, Rowland M. Loss of household protection from use of insecticide-treated nets against pyrethroid-resistant mosquitoes. Benin Emerg Infect Dis. 2012;18:1101\u20136.","journal-title":"Benin Emerg Infect Dis"},{"key":"4336_CR43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3201\/eid1302.060631","volume":"13","author":"R N'Guessan","year":"2007","unstructured":"N\u2019Guessan R, Corbel V, Akogbeto M, Rowland M. Reduced efficacy of insecticide-treated nets and indoor residual spraying for malaria control in pyrethroid resistance area. Benin Emerg Infect Dis. 2007;13:199\u2013206.","journal-title":"Benin Emerg Infect Dis"},{"key":"4336_CR44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ibmb.2011.03.012","volume":"41","author":"CS Wondji","year":"2011","unstructured":"Wondji CS, Dabire RK, Tukur Z, Irving H, Djouaka R, Morgan JC. Identification and distribution of a GABA receptor mutation conferring dieldrin resistance in the malaria vector Anopheles funestus in Africa. Insect Biochem Mol Biol. 2011;41:484\u201391.","journal-title":"Insect Biochem Mol Biol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04336-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04336-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04336-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T09:06:39Z","timestamp":1668157599000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04336-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4336"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04336-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.10.12.511866","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by the Ethics Review Committees of Ministry of Health Benin (Ethical decision n\u00b026 of 28 June 2019, renewal n\u00b034 of 9 September 2020) and the London School of Hygiene and Tropical Medicine (Ref: 1705). Human volunteer sleepers who slept in the huts to attract mosquitoes gave informed consent before they participated in the study. The study details and consent forms were explained to them in their local language by an interpreter. A stand-by nurse was available to sleepers throughout the study to assess any case of fever and persistent headache. Any sleeper testing positive for malaria was immediately withdrawn from the study and treated effectively in line with local public health practices.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}